PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker.
about
Ascorbic acid for the treatment of Charcot-Marie-Tooth diseasePolytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease.Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy.Caveats in the Established Understanding of CMT1A.PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients.
P2860
Q24187132-443216C5-050F-4929-9087-B7DFE35A8A00Q34788066-EA8DE15D-087C-4764-926E-D72FD028D508Q38979315-9BB0706D-E457-4DF5-BCB4-A82F6CE5E129Q40408847-0A2E1FBB-D58F-4410-8546-395DCA5B5562Q41357926-7BC49C35-7B00-493E-86CE-5B643475A315Q45875397-A5979A51-EC66-4A97-BAB5-6A5A40FE0F8EQ47288315-2B9EF531-5BE5-4FCF-B13B-F770E31F5B76
P2860
PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
PMP22 messenger RNA levels in ...... rcot-Marie-Tooth 1A biomarker.
@en
PMP22 messenger RNA levels in ...... rcot-Marie-Tooth 1A biomarker.
@nl
type
label
PMP22 messenger RNA levels in ...... rcot-Marie-Tooth 1A biomarker.
@en
PMP22 messenger RNA levels in ...... rcot-Marie-Tooth 1A biomarker.
@nl
prefLabel
PMP22 messenger RNA levels in ...... rcot-Marie-Tooth 1A biomarker.
@en
PMP22 messenger RNA levels in ...... rcot-Marie-Tooth 1A biomarker.
@nl
P2093
P2860
P50
P356
P1433
P1476
PMP22 messenger RNA levels in ...... rcot-Marie-Tooth 1A biomarker.
@en
P2093
Alessandra Solari
Angelo Schenone
CMT-TRIAAL Group
Davide Pareyson
Davide Radice
Davide Visigalli
Elisabetta Fiorina
Mary M Reilly
P2860
P304
P356
10.1093/BRAIN/AWU071
P407
P577
2014-05-08T00:00:00Z